Published in
Elsevier, Annals of Oncology, (30), p. v888-v889, 2019
DOI: 10.1093/annonc/mdz394.047
Links
Tools
IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Journal article published in 2019 by
E. Grande,
J. A. Arranz Arija,
M. Galsky,
U. F. F. De Giorgi,
M. De Santis,
Id D. Davis,
X. Garcia del Muro,
M. Mencinger,
E. Kikuchi,
A. Rezazadeh Kalebasty,
S. H. Park,
B. Y. Alekseev,
M. Gumus,
F. A. B. Schutz,
M. Özgüroğlu 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 